Global NGS Oncology Market to Reach $51.78 Billion by 2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “NGS Oncology Market – A Global and Regional Analysis: Focus on Offering, Sequencing Technology, Workflow, Application, End User, and Region – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. Global NGS Oncology Market Industry Overview The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 … [Read more…]

Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. Hematologic Malignancies Testing Market: Industry Overview The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from … [Read more…]

SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Novel Vaccine Company Expands Leadership Team and Establishes US Presence OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive Officer (CEO). He also joins the Board of Directors. Sumi Biswas, the … [Read more…]

Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments

Dr Jennifer Schneider appointed CEO, Dr Helen Bright joins as VP of Research & Development, and Professor David Roblin will Chair the Board of Directors Senior appointments support acceleration of novel immunotherapies to treat infectious disease, leveraging the Alphamer platform Team expansion follows recent £24m investment from Boehringer Ingelheim Venture Fund, Evotec SE and Novo … [Read more…]

Ixaka Appoints Karen Miller as Chief Scientific Officer

LONDON–(BUSINESS WIRE)–Ixaka Ltd, an integrated cell and gene therapy company focused on boosting the natural power of the body to cure disease, today announces the appointment of Dr Karen Miller as Chief Scientific Officer. Karen joins Ixaka bringing more than 30 years of experience in the biotech and pharma industry, leading drug discovery, preclinical and … [Read more…]

Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer … [Read more…]

LifeWorks files Management Information Circular for special meeting of shareholders

The Board of Directors unanimously recommends that shareholders vote FOR the Arrangement Not for distribution to U.S. news wire services or for dissemination in the U.S. TORONTO–(BUSINESS WIRE)–LifeWorks Inc. (TSX: LWRK, “LifeWorks” or the “Company”), today announced that it has filed and is in the process of mailing the Management Information Circular and related materials … [Read more…]

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 9, 2022

BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2022 results on Tuesday, August 9, 2022. The Company will host a conference call on Tuesday, August 9, 2022, at 10:00 a.m. ET to discuss these results. To access the call, … [Read more…]

Strengthening the Health Science Industry by Increasing the Adoption of Canadian Innovations and Focusing on Women’s Leadership

TORONTO–(BUSINESS WIRE)–The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is excited to announce the expansion of Canada’s Early Adopter Health Network (EAHN™) and the launch of its new Women in Health Initiative (WiHI) to train women to further ensure their participation and career success in the … [Read more…]

SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer

Experienced Biotech Leader and Capital Markets Professional Elevated to Chief Financial Officer from Chief Business Officer Role Appointment Effective July 11, 2022 WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it has appointed Micah Zajic, as the company’s Chief Financial Officer, … [Read more…]